254 related articles for article (PubMed ID: 32226349)
1. Melanoma Radiological Surveillance: A Review of Current Evidence and Clinical Challenges.
Howard MD
Yale J Biol Med; 2020 Mar; 93(1):207-213. PubMed ID: 32226349
[TBL] [Abstract][Full Text] [Related]
2. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
Rueth NM; Xing Y; Chiang YJ; Cromwell KD; Ross MI; Lee JE; Gershenwald JE; Royal RE; Cormier JN
Ann Surg; 2014 Jun; 259(6):1215-22. PubMed ID: 24096759
[TBL] [Abstract][Full Text] [Related]
3. A review of diagnostic imaging in melanoma.
Dancey AL; Mahon BS; Rayatt SS
J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1275-83. PubMed ID: 18694659
[TBL] [Abstract][Full Text] [Related]
4. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
Patnana M; Bronstein Y; Szklaruk J; Bedi DG; Hwu WJ; Gershenwald JE; Prieto VG; Ng CS
Clin Radiol; 2011 Mar; 66(3):224-36. PubMed ID: 21295201
[TBL] [Abstract][Full Text] [Related]
5. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
[TBL] [Abstract][Full Text] [Related]
6. Imaging in cutaneous melanoma.
Ho Shon IA; Chung DK; Saw RP; Thompson JF
Nucl Med Commun; 2008 Oct; 29(10):847-76. PubMed ID: 18769303
[TBL] [Abstract][Full Text] [Related]
7. Melanoma patient imaging in the era of effective systemic therapies.
Stodell M; Thompson JF; Emmett L; Uren RF; Kapoor R; Saw RPM
Eur J Surg Oncol; 2017 Aug; 43(8):1517-1527. PubMed ID: 28625798
[TBL] [Abstract][Full Text] [Related]
8. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
[TBL] [Abstract][Full Text] [Related]
10. [Melanoma, from diagnosis to treatment].
Baroudjian B; Pagès C; Lebbé C
Rev Infirm; 2016 Mar; (219):16-8. PubMed ID: 26944639
[TBL] [Abstract][Full Text] [Related]
11. Malignant Melanoma: Diagnostic and Management Update.
Knackstedt T; Knackstedt RW; Couto R; Gastman B
Plast Reconstr Surg; 2018 Aug; 142(2):202e-216e. PubMed ID: 30045186
[TBL] [Abstract][Full Text] [Related]
12. PET/Computed Tomography and Patient Outcomes in Melanoma.
Rohren EM
PET Clin; 2015 Apr; 10(2):243-54. PubMed ID: 25829089
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma.
Pfannenberg C; Aschoff P; Schanz S; Eschmann SM; Plathow C; Eigentler TK; Garbe C; Brechtel K; Vonthein R; Bares R; Claussen CD; Schlemmer HP
Eur J Cancer; 2007 Feb; 43(3):557-64. PubMed ID: 17224266
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic accuracy of imaging studies for initial staging of T2b to T4b melanoma patients: A cross-sectional study.
Riquelme-Mc Loughlin C; Podlipnik S; Bosch-Amate X; Riera-Monroig J; Barreiro A; Espinosa N; Moreno-Ramírez D; Giavedoni P; Vilana R; Sánchez M; Vidal-Sicart S; Carrera C; Malvehy J; Puig S
J Am Acad Dermatol; 2019 Dec; 81(6):1330-1338. PubMed ID: 31163236
[TBL] [Abstract][Full Text] [Related]
15. Whole-body MRI with diffusion-weighted sequences compared with 18 FDG PET-CT, CT and superficial lymph node ultrasonography in the staging of advanced cutaneous melanoma: a prospective study.
Jouvet JC; Thomas L; Thomson V; Yanes M; Journe C; Morelec I; Bracoud L; Durupt F; Giammarile F; Berthezene Y
J Eur Acad Dermatol Venereol; 2014 Feb; 28(2):176-85. PubMed ID: 23331931
[TBL] [Abstract][Full Text] [Related]
16. Role of imaging methods in metastatic melanoma.
Li Q; Yang J
Onkologie; 2012; 35(9):522-6. PubMed ID: 23007153
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of adding FDG-PET or CT to the diagnostic work-up of patients with stage III melanoma.
Bastiaannet E; Uyl-de Groot CA; Brouwers AH; van der Jagt EJ; Hoekstra OS; Oyen W; Verzijlbergen F; van Ooijen B; Thompson JF; Hoekstra HJ
Ann Surg; 2012 Apr; 255(4):771-6. PubMed ID: 22367443
[TBL] [Abstract][Full Text] [Related]
18. [The latest diagnostical methods and therapy in melanoma].
Wojas-Pelc A; Rajzer L; Jaworek A; Woźniak W
Przegl Lek; 2006; 63(8):674-80. PubMed ID: 17441381
[TBL] [Abstract][Full Text] [Related]
19. [Advancements in the diagnosis of melanoma].
Liszkay G
Magy Onkol; 2015 Mar; 59(1):68-72. PubMed ID: 25763916
[TBL] [Abstract][Full Text] [Related]
20. Metastatic melanoma - a review of current and future treatment options.
Maverakis E; Cornelius LA; Bowen GM; Phan T; Patel FB; Fitzmaurice S; He Y; Burrall B; Duong C; Kloxin AM; Sultani H; Wilken R; Martinez SR; Patel F
Acta Derm Venereol; 2015 May; 95(5):516-24. PubMed ID: 25520039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]